Major histocompatibility complex class II molecules presenting tetanus toxoid peptides (MHC II-TT) (MHC II-TT)

MHC class II molecules presenting tetanus toxoid peptides are specialized protein complexes found on the surface of professional antigen-presenting cells (APCs), such as dendritic cells and B cells (Janeway et al., Immunobiology, 2001). These complexes consist of a heterodimeric MHC class II protein, most commonly HLA-DR in humans, bound to a processed peptide fragment derived from the tetanus toxoid protein produced by Clostridium tetani (UniProt P06790). The primary biological function of this complex is to present the foreign antigen to the T-cell receptor (TCR) of CD4+ T helper cells, thereby initiating a robust adaptive immune response (StatPearls, "Antigen Presentation", 2023). This interaction is fundamental to the efficacy of tetanus vaccines and is increasingly utilized in immunotherapy as a "helper" epitope to boost responses against tumors or other pathogens (PubMed: 25762134). Because the majority of the global population has been immunized against tetanus, these pMHC complexes can rapidly recruit pre-existing memory T cells to provide "universal help" in various therapeutic contexts, such as enhancing the activity of CAR-T cells or dendritic cell vaccines (Nature, 2015, 519:366-369). Overall, the MHC II-tetanus toxoid complex serves as a critical bridge between innate and adaptive immunity, making it a valuable tool in both prophylactic vaccination and advanced cancer immunotherapy.

Other names

HLA-DR-tetanus toxoid complexMHC class II-tetanus toxoid peptide complexTetanus toxoid-specific MHC IIpMHC II (Tetanus Toxoid)

Activation of CD4+ T helper cells through T-cell receptor (TCR) recognition of the peptide-MHC complex